Non-Hodgkin Lymphoma (NHL) Market to Witness Robust Expansion by 2026

The Non-Hodgkin Lymphoma (NHL) Market size depends upon several factors that have direct or indirect influence on the demand and supply chain. The report published by Stratview Research throws light on the vital extracts of many such factors derived using different types of analysis like supply chain analysis, etc. These methods help in analysing the core strength of the companies, identifying their growth strategies, recognising their gaps as well as opportunities to lay out an effective roadmap which leads to higher profitability.


By type, the non-Hodgkin lymphoma (NHL) market has been bifurcated into hospitals and clinics. Under these, the hospital segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of established infrastructure and skilled healthcare staff.

By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to the rising number of people suffering from lymphoma cancer coupled with the presence of key market players such as Bristol Myers Squibb (US) and Celgene Corporation (US). The market growth in the Asia-Pacific region is expected to be driven by the increasing prevalence of cancer disease.

Key Players:

  • F. Hoffmann-La Roche AG (Switzerland)
  • Johnson & Johnson (US)
  • The Merck Group (Germany)
  • Bristol Myers Squibb (US)
  • Celgene Corporation (US)
  • Eli Lilly and Company (US)
  • GlaxoSmithKline plc (UK)
  • Bayer AG (Germany)
  • AstraZeneca plc (UK)
  • The Takeda Pharmaceutical Company Limited (Japan).

Custom Research:

Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to Or connect with our experts at +1-313-307-4176.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.

Publicado en Health en agosto 18 at 05:32
Comentarios (0)
No login
Inicie sesión o regístrese para enviar su comentario
Cookies on De Gente Vakana.
This site uses cookies to store your information on your computer.